Latest Articles
NMM/OMT

Lymphatic osteopathic manipulative treatment reduces duration of deltoid soreness after Pfizer/BioNTech COVID-19 vaccine

Sylvia Marshall, OMS III; Sara Winter, PA-C, MS; and John D. Capobianco, DO, FAAO
Pfizer-BioNTech BNT162b2 is one of the three U.S. Food and Drug Administration (FDA)-approved vaccines for the prevention of COVID-19. Its most common side effect, injection site pain, occurs because of locally recruited inflammatory mediators and is mitigated by the lymphatic system. Side effects may discourage individuals from receiving vaccines; therefore, reducing the duration of injection site pain can promote vaccination compliance. Osteopathic manipulative treatments (OMT) can directly affect the physiology underlying muscle soreness; however, there is currently no literature that supports the use of OMT in this scenario. In this case report, an otherwise healthy male presented with acute left deltoid soreness after receiving the Pfizer COVID-19 vaccine. Three hours after being treated with lymphatic OMT, the severity of the pain was significantly reduced and was alleviated 8 hours after onset in comparison to the median duration of 24–48 hours.
Public Health and Primary Care

A novel movement system screen for primary care providers: a multisite, observational study

Christine Kettle, DPT; Lauren McKay, DO; Anthony M. Cianciolo, DO; Stephen M. Kareha, DPT, ATC, PhD; and Cara E. Ruggeri, DO
The authors evaluated whether a screening tool would be able to accurately screen individuals for movement system disorders (MSDs), explore comorbidities that may predict the prevalence of MSDs, and identify why people do not discuss these problems with their primary care provider.
NMM/OMT

Cranial manipulation affects cholinergic pathway gene expression in aged rats

Ramu Anandakrishnan, PhD; Hope Tobey, DO; Steven Nguyen, BS; Osscar Sandoval, BS; Bradley G. Klein, PhD; and Blaise M. Costa, PhD
Age-dependent dementia is a devastating disorder afflicting a growing older population. Although pharmacological agents improve symptoms of dementia, age-related comorbidities combined with adverse effects often outweigh their clinical benefits. Therefore, nonpharmacological therapies are being investigated as an alternative. In a previous pilot study, aged rats demonstrated improved spatial memory after osteopathic cranial manipulative medicine (OCMM) treatment. In this continuation of the aforementioned study, the authors examine the effect of OCMM on gene expression to elicit possible explanations for the improvement in spatial memory.

2021 George W. Northup, DO, Medical Writing Award

Journal of Osteopathic Medicine and the American Osteopathic Association congratulate John C. Licciardone, DO, and Robert J. Gatchel, PhD, recipients of the George W. Northup, DO, Medical Writing Award for their article, “Osteopathic Medical Care With and Without Osteopathic Manipulative Treatment in Patients With Chronic Low Back Pain: A Pain Registry–Based Study.” Read the full article here.

Journal of Osteopathic Medicine launches inaugural issues

Journal of Osteopathic Medicine (JOM) – known for 119 years as the Journal of the American Osteopathic Association – published its inaugural issue in January 2021. Learn how the osteopathic medical profession’s journal of record has been refreshed and refocused by reading the introductory Editorial from Dr. Ross Zafonte, JOM’s Editor in Chief; a Q&A with Melissa Schmidt, JOM’s Director; and an announcement from AOA President Dr. Thomas Ely and CEO Dr. Kevin Klauer.

Clinical Image

Epiglottic squamous cell carcinoma

A 56-year-old woman with history of epiglottic squamous cell cancer, chronic obstructive pulmonary disease, requiring 4 L O2 supplementation, asthma, coronary artery disease, myocardial infarction, gastroesophageal reflux disease, dysphagia, and tobacco abuse presented for laparoscopic jejunostomy tube placement to supplement nutritional intake during radiation therapy. Less than one month prior to presentation, she underwent awake intubation utilizing video laryngoscopy with a full view of the glottis. A computed tomography scan of the neck demonstrated a 3.1 × 1.8 cm epiglottic mass and nasolaryngoscopy revealed a mass on the epiglottis to the mid-laryngeal surface without obstruction of the glottis. Read more